We are live on ! Find out more
ACM

Archon Capital Management Portfolio holdings

AUM $177M
1-Year Est. Return 108.05%
This Fund
S&P 500
This Quarter Est. Return
-10.86%
1 Year Est. Return
+108.05%
3 Year Est. Return
+131.1%
5 Year Est. Return
+145.05%
10 Year Est. Return
+2,088.21%
AUM
$123M
AUM Growth
-$167M
Cap. Flow
-$141M
Cap. Flow %
-114.18%
Top 10 Hldgs %
76.39%
Holding
37
New
4
Increased
1
Reduced
19
Closed
13

Top Buys

Rank Stock Value
1
ORN icon
Orion Group Holdings
ORN
+$2.4M
2
PBPB
Potbelly
PBPB
+$2.21M
3
DRS icon
Leonardo DRS
DRS
+$1.95M

Top Sells

Rank Stock Value
1
PCRX icon
Pacira BioSciences
PCRX
+$15.7M
2
EZPW icon
Ezcorp Inc
EZPW
+$9.36M
3
ZM icon
Zoom
ZM
+$9.01M
4
KRMD icon
KORU Medical Systems
KRMD
+$6.64M
5
ARAY icon
Accuray
ARAY
+$6.45M

Sector Composition

Rank Sector Weight
1 Healthcare 22.8%
2 Technology 17.98%
3 Consumer Discretionary 11.84%
4 Industrials 8.77%
5 Financials 7.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BMBL icon
26
Bumble
BMBL
$372M
-561,237
Closed -$6.37M
HBIO icon
27
Harvard Bioscience
HBIO
$27.5M
-26,086
Closed -$1.11M
IWM icon
28
PUT
iShares Russell 2000 ETF
IWM
$79.8B
-40,000
Closed -$8.41M
KOPN icon
29
Kopin
KOPN
$652M
-3,192,786
Closed -$5.75M
OSUR icon
30
OraSure Technologies
OSUR
$279M
-206,742
Closed -$1.27M
PCRX icon
31
Pacira BioSciences
PCRX
$1.04B
-536,525
Closed -$15.7M
QQQ icon
32
PUT
Invesco QQQ Trust
QQQ
$453B
-110,000
Closed -$48.8M
SPY icon
33
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$790B
-40,000
Closed -$20.9M
TMCI icon
34
Treace Medical Concepts
TMCI
$280M
-130,097
Closed -$1.7M
TTMI icon
35
TTM Technologies
TTMI
$12B
-197,894
Closed -$3.1M
ZUO
36
DELISTED
Zuora, Inc.
ZUO
-383,320
Closed -$3.5M
EMKR
37
DELISTED
Emcore Corp
EMKR
-1,255,258
Closed -$4.33M

Similar funds

Archon Capital Management's Q2 2024 Portfolio in Review

As of Q2 2024, Archon Capital Management held 37 positions worth $123M, down 57% from $290M the previous quarter. Its ten largest holdings account for 76% of the portfolio.

Archon Capital Management withdrew a net $141M in Q2 2024, closing 13 positions and reducing 19 holdings. Its most notable exit was Pacira BioSciences, an estimated $15.7M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 23% of assets, down from 29% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Archon Capital Management opened a new position in Orion Group Holdings worth $2.58M.

  • Archon Capital Management's largest Q2 2024 buy was Orion Group Holdings: 271,387 shares worth $2.58M.
  • Archon Capital Management added most to Potbelly in Q2 2024, an estimated $2.21M increase.
  • Archon Capital Management's biggest Q2 2024 reduction was Ezcorp Inc, cutting an estimated $9.36M.
  • Archon Capital Management fully exited Pacira BioSciences in Q2 2024, selling an estimated $15.7M.
  • Archon Capital Management's ten largest holdings make up 76% of its $123M portfolio in Q2 2024.
  • Archon Capital Management opened 4 new positions and closed 13 in Q2 2024.
  • Archon Capital Management's portfolio value fell 57% quarter-over-quarter to $123M.

Based on Archon Capital Management's 13F filing for Q2 2024, filed 14 Aug 2024.